Concepedia

Tiffany K. Ricks

TK

Statistics

Publications

23

Citations

2.8K

H-Index

22

Active since

2006

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Center for Devices and Radiological Health

University of North Carolina at Chapel Hill

Université Paris Cité

Tiffany K. Ricks is an author at Center for Drug Evaluation and Research specializing in oncology, medicine, and pharmacology.

Publications per year

2006–2025

23

Publications

23

FDA Approval: Blinatumomab

Donna Przepiorka, Chia‐Wen Ko, Albert Deisseroth et al. · Clinical Cancer Research · 2015 · 364 citations

Medicine, Hematology, Oncology +17

Kinetic Scaffolding Mediated by a Phospholipase C–β and G <sub>q</sub> Signaling Complex

Gary L. Waldo, Tiffany K. Ricks, Stephanie N. Hicks et al. · Science · 2010 · 227 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer

Jaleh Fallah, Sundeep Agrawal, Haley Gittleman et al. · Clinical Cancer Research · 2022 · 220 citations · Full text

Medicine, Oncology, Pharmacology +17

Protease-Activated Receptor-2 Is Essential for Factor VIIa and Xa–Induced Signaling, Migration, and Invasion of Breast Cancer Cells

Dionne Morris, Yu‐Qiang Ding, Tiffany K. Ricks et al. · Cancer Research · 2006 · 217 citations

Medicine, Cancer Biology, Oncology +14

FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma

Elaine Chang, Chana Weinstock, Lijun Zhang et al. · Clinical Cancer Research · 2020 · 183 citations · Full text

Medicine, Oncology, Pharmacology +11

1–5 of 23